https://www.selleckchem.com/pr....oducts/pf-06700841.h
Multiple investigators have described an increased incidence of thromboembolic events in SARS-CoV-2-infected individuals. Data concerning hemostatic complications in children hospitalized for COVID-19/multisystem inflammatory syndrome in children (MIS-C) are scant. To share our experience in managing SARS-CoV-2-associated pro-coagulant state in hospitalized children. D-dimer values were recorded at diagnosis in children hospitalized for SARS-CoV-2-related manifestations. In moderately to critically ill patients and MIS-C cases, coag
Synes godt om
Kommentar
Del
